Correvio partners with Teson for commercializing cardiac drug in China
12 Mar 2020 //
BIOSPECTRUM ASIA
Correvio suffers fresh blow as heart drug fails to win FDA panel backing
11 Dec 2019 //
REUTERS
Correvio slumps after FDA say benefits of heart drug do not outweigh risks
07 Dec 2019 //
REUTERS
Correvio Highlights FDA Acceptance of United Therapeutics` Trevyent NDA
11 Sep 2019 //
BIOSPACE
Correvio partner begins patient enrollment in ph 3 study on Brinavess in China
18 May 2018 //
PHARMABIZ